Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings. — CFSMEATLAS
Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings.
Nelson, Todd, Zhang, Lan-Xin, Guo, Hui et al. · Frontiers in neurology · 2021 · DOI
Quick Summary
This review examined brain imaging studies to understand how ME/CFS affects the brainstem, which is the part of the brain that controls vital functions like heart rate, breathing, and sleep. Researchers found that people with ME/CFS often show changes in the brain's structure and how different brain regions communicate with each other. These findings suggest that problems in the brainstem might explain many ME/CFS symptoms, though more research is needed to fully understand the connections.
Why It Matters
This review consolidates emerging evidence that brainstem dysfunction may be a key biological feature of ME/CFS, helping legitimize the search for measurable brain abnormalities in this condition. Understanding brainstem involvement could guide future diagnostic approaches and targeted therapeutic interventions, improving clinical management and validating the biomedical nature of ME/CFS.
Observed Findings
MRI studies frequently reported structural changes in brainstem white and gray matter in ME/CFS patients
Abnormal functional connectivity was detected within the brainstem and between the brainstem and other brain regions
Proposed mechanisms include astrocyte dysfunction, cerebral perfusion impairment, impaired nerve conduction, and neuroinflammation
Brainstem abnormalities may partially explain the heterogeneous symptom presentations across ME/CFS patients
Inferred Conclusions
The brainstem plays an important role in ME/CFS pathophysiology based on convergent MRI evidence
Multiple potential mechanisms (inflammatory, vascular, and neuronal) may underlie brainstem dysfunction in this condition
Brainstem-focused research could advance understanding of ME/CFS heterogeneity and inform future diagnostic and therapeutic approaches
Remaining Questions
Are brainstem abnormalities present in all ME/CFS patients or only specific subgroups, and do they correlate with symptom severity or type?
Which proposed mechanisms (neuroinflammation, perfusion impairment, astrocyte dysfunction, etc.) are primary versus secondary, and how do they interact?
Can brainstem imaging findings serve as reliable biomarkers for ME/CFS diagnosis or for monitoring treatment response?
What This Study Does Not Prove
This review does not prove that brainstem abnormalities cause ME/CFS symptoms—it documents associations found on imaging studies. The findings are correlational and do not establish definitive causation or identify which abnormalities are primary versus secondary. Individual study limitations and the heterogeneous nature of findings mean this review cannot yet provide a unified explanation for all ME/CFS pathophysiology.